(586123), Y. B., (146367), X. W., (130507), X. D., (580671), Q. M., & (3389774), H. H. (2024). Table3_Immune-related adverse events in small-cell lung cancer patients treated with immune checkpoint inhibitors: A comprehensive analysis from the FDA adverse event reporting system.pdf.
Chicago Style (17th ed.) Citation(586123), Yifeng Bai, Xiaomei Wang (146367), Xiaoqin Dai (130507), Qinghua Ma (580671), and Honglin Hu (3389774). Table3_Immune-related Adverse Events in Small-cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis from the FDA Adverse Event Reporting System.pdf. 2024.
MLA (9th ed.) Citation(586123), Yifeng Bai, et al. Table3_Immune-related Adverse Events in Small-cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Comprehensive Analysis from the FDA Adverse Event Reporting System.pdf. 2024.